Cancer Institute Clinical Trials - Lung

#130574 NCT01999673
Title: SUNRISE:  A Phase III, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial of Bavituximab Plus Docetaxel versus Docetaxel Alone as Second-Line Therapy in Patients with Stage IIIb/IV Non-Squamous Non‑Small-Cell Lung Cancer
Study Location: Temple Main Campus


For more information or to enroll in a study please call, 254-724-5407.


Print
Text Size
A
A
A